Type E botulism associated with fish product consumption – Germany and Spain, 21 December 2016
This document assesses the risk to human health posed by a multi-country incident of botulism neurotoxin type E, possibly associated with consumption of a commercially-available dried and salted fish product.
Four confirmed botulism E cases in Germany and two probable cases in Spain have been reported to date.
The clustering in time and very likely link to the consumption of commercially available salted and dried roach (Rutilus rutilus) indicates that this fish product may be a common source. Five human cases have a Russian background and one case has a Kazakh background. The implicated fish product has been distributed to several EU/EEA Member States and intensive recall measures have been initiated in the countries concerned following the notification from Germany to the Rapid Alert System for Food and Feed (RASFF), on 25 November.
Botulism neurotoxin type E is not an uncommon contamination in fish products, which have been poorly eviscerated and/or self-salted at home. Contamination in commercial fish products has also been reported. For this outbreak, the populations at the greatest risk are those who traditionally consume salted and dried roach. The risk for other population groups is very low in EU/EEA.
In view of the rapid initiation of recalls and targeted public warnings, the risk that new cases linked to the outbreak will appear in the EU/EEA is considered to be very low. The main potential residual risk of exposure relates to consumers still keeping the product at home who may not been made aware of the public warnings, or stores that may not have received notification of the recall and are continuing to sell the implicated fish product. Finally, there is no risk of person-to-person transmission.
Risk assessment: The risk of variant Creutzfeldt-Jakob disease transmission via blood and plasma-derived medicinal products manufactured from donations obtained in the United Kingdom
3 Aug 2021 - ECDC assessed the risk to the EU/EEA of the presence and the possible transmission of prions, which have been linked to to Creutzfeldt-Jakob disease, by blood and plasma-derived medicinal products (PDMPs) manufactured from donations obtained in the UK.
Rapid Risk Assessment: Extreme rainfall and catastrophic floods in western Europe
29 Jul 2021 - Extreme rainfall on 14 and 15 July 2021 and subsequent flooding in Western Europe has taken a high number of human lives and caused substantial damage to community infrastructure and the environment. This rapid risk assessment focuses on the most common infectious diseases and health risks associated with flood-affected areas, taking into account evidence from previous similar events in Europe.
Rapid risk assessment: Increase in OXA-244 -producing Escherichia coli in the European Union/European Economic Area and the UK since 2013, first update
20 Jul 2021 - Rapid risk/outbreaks assessment aim at supporting the countries and the European Commission in their preparedness and response to a public health threat. They provide a timely summary and risk assessment of a public health threat for EU/EEA countries related to a specific event. They also include potential options for response. As outbreaks or public health events develop, ECDC may issue updated risk assessments.